PATENT CLAIM ANALYSIS

Application Number: 15875606
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "182000"]

Abstract:
A method of modulating an immune response. The method includes administering a treatment comprising delta 5-androsten-3B, 17B-diol, delta 5-androsten-3B, 7B, 17B-triol, or both.

Claim (Index 1):
A method of modulating an immune response, the method comprising:\n administering a treatment comprising delta 5-androsten-3B, 17B-diol, delta 5-androsten-3B, 7B, 17B-triol, or both.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14394147', '12394578', '15434971', '14394161', '15374227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6916842384804962
- 35 USC 102 Novelty (BERT): 0.487044284353392
- Combined Prediction Score: 0.6712202430677858
- Mean Citation Score: 132.54742399999998
- Max Citation Score: 135.85657
- Similarity Product: 86.01549557986975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test